Zurich Cantonal Bank’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4K | Buy |
+906
| New | +$12.1K | ﹤0.01% | 2478 |
|
|
2023
Q4 | – | Sell |
-2,823
| Closed | -$31.5K | – | 2750 |
|
|
2023
Q3 | $31.5K | Hold |
2,823
| – | – | ﹤0.01% | 2672 |
|
|
2023
Q2 | $60.4K | Hold |
2,823
| – | – | ﹤0.01% | 2545 |
|
|
2023
Q1 | $114K | Sell |
2,823
-319
| -10% | -$15.2K | ﹤0.01% | 2215 |
|
|
2022
Q4 | $146K | Sell |
3,142
-68
| -2% | -$3.1K | ﹤0.01% | 2023 |
|
|
2022
Q3 | $167K | Hold |
3,210
| – | – | ﹤0.01% | 1858 |
|
|
2022
Q2 | $152K | Sell |
3,210
-30
| -0.9% | -$1.63K | ﹤0.01% | 1960 |
|
|
2022
Q1 | $231K | Buy |
3,240
+417
| +15% | +$27.1K | ﹤0.01% | 1795 |
|
|
2021
Q4 | $211K | Hold |
2,823
| – | – | ﹤0.01% | 2034 |
|
|
2021
Q3 | $160K | Hold |
2,823
| – | – | ﹤0.01% | 2064 |
|
|
2021
Q2 | $124K | Hold |
2,823
| – | – | ﹤0.01% | 2100 |
|
|
2021
Q1 | $139K | Hold |
2,823
| – | – | ﹤0.01% | 1993 |
|
|
2020
Q4 | $119K | Hold |
2,823
| – | – | ﹤0.01% | 2139 |
|
|
2020
Q3 | $129K | Hold |
2,823
| – | – | ﹤0.01% | 1863 |
|
|
2020
Q2 | $142K | Buy |
2,823
+1,772
| +169% | +$91.7K | ﹤0.01% | 1758 |
|
|
2020
Q1 | $54K | Hold |
1,051
| – | – | ﹤0.01% | 1908 |
|
|
2019
Q4 | $65K | Buy |
1,051
+341
| +48% | +$21.1K | ﹤0.01% | 1992 |
|
|
2019
Q3 | $43K | Hold |
710
| – | – | ﹤0.01% | 2134 |
|
|
2019
Q2 | $60K | Hold |
710
| – | – | ﹤0.01% | 1941 |
|
|
2019
Q1 | $68K | Buy |
710
+32
| +5% | +$2.87K | ﹤0.01% | 1810 |
|
|
2018
Q4 | $48K | Hold |
678
| – | – | ﹤0.01% | 2053 |
|
|
2018
Q3 | $58K | Buy |
678
+129
| +23% | +$12.9K | ﹤0.01% | 2067 |
|
|
2018
Q2 | $64K | Hold |
549
| – | – | ﹤0.01% | 1961 |
|
|
2018
Q1 | $44K | Hold |
549
| – | – | ﹤0.01% | 2143 |
|
|
2017
Q4 | $32K | Hold |
549
| – | – | ﹤0.01% | 2264 |
|
|
2017
Q3 | $26K | Hold |
549
| – | – | ﹤0.01% | 2163 |
|
|
2017
Q2 | $20K | Buy |
549
+314
| +134% | +$10K | ﹤0.01% | 2250 |
|
|
2017
Q1 | $7K | Hold |
235
| – | – | ﹤0.01% | 2530 |
|
|
2016
Q4 | $8K | Hold |
235
| – | – | ﹤0.01% | 2481 |
|
|
2016
Q3 | $6K | Hold |
235
| – | – | ﹤0.01% | 2493 |
|
|
2016
Q2 | $5K | Hold |
235
| – | – | ﹤0.01% | 2490 |
|
|
2016
Q1 | $7K | Hold |
235
| – | – | ﹤0.01% | 2456 |
|
|
2015
Q4 | $8K | Hold |
235
| – | – | ﹤0.01% | 2447 |
|
|
2015
Q3 | $8K | Hold |
235
| – | – | ﹤0.01% | 2203 |
|
|
2015
Q2 | $11K | Hold |
235
| – | – | ﹤0.01% | 1317 |
|
|
2015
Q1 | $7K | Buy |
+235
| New | +$9.14K | ﹤0.01% | 1598 |
|
Other funds holding ENTA
FCM
KAM
DTC
VCM
VPM
SSC
Zurich Cantonal Bank's ENTA Position: Q1 2026 in Review
Zurich Cantonal Bank opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 906 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #2478 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in ENTA as recently as Q3 2023.
Zurich Cantonal Bank first reported a position in ENTA in Q1 2015 and has held it in 36 quarters since. The position peaked at $231K in Q1 2022. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.
- Zurich Cantonal Bank held 906 shares of Enanta Pharmaceuticals worth $11.4K as of Q1 2026.
- Enanta Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
- Enanta Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2478 holding.
- Zurich Cantonal Bank first reported a position in Enanta Pharmaceuticals in Q1 2015 and has held it in 36 quarters since.
- Zurich Cantonal Bank's Enanta Pharmaceuticals position peaked at $231K in Q1 2022.
- 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.